Retatrutide is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, representing one of the most comprehensive metabolic research tools available. By co-activating all three incretin and glucagon receptor pathways, Retatrutide has been studied in preclinical and early-phase clinical research for its pronounced effects on body weight reduction, glycemic regulation, lipid metabolism, and energy expenditure. Its tri-agonist profile distinguishes it from single and dual agonist compounds. PeptideBull supplies Retatrutide at research-grade purity for authorized laboratory applications. Not for human or veterinary consumption.
Research Articles
GLP-1 Peptides: Semaglutide, Tirzepatide, Retatrutide Comparison
A comprehensive scientific comparison of GLP-1 peptides, including Semaglutide, Tirzepatide, and Retatrutide. Delve into...
Retatrutide Triple Agonist Metabolic Research: A Comprehensive Review
Dive into the scientific mechanisms of Retatrutide, a novel triple agonist peptide. Explore current research findings on...
GLP-1 Peptides: Semaglutide, Tirzepatide, Retatrutide Comparison
Discover the differences and similarities between Semaglutide, Tirzepatide, and Retatrutide. This article delves into th...